Bladder Cancer - A Joint SIU-ICUD International Consultation - Editors Peter Black and Paolo Gontero

Aug 23, 2026

Uploaded by Rizky

Bladder Cancer: A Joint SIU-ICUD International Consultation, prepared for the Lisbon, Portugal meeting on October 19, 2017, consolidates expert guidance across epidemiology, prevention, screening, diagnosis, evaluation, pathology, and related evidence-based methods. The publication is organized around scientific committee work, covering guideline development steps, grading of recommendations, and detailed clinical domains from endoscopic assessment and imaging to histological grading and prognostic factors. It is published by SIU with coordinated medical editing and international committee contributions.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages916

Reading Time38 h 28 min

AccessFree to download

Abbreviations Used in the Text

Preface

Introduction

Evidence-Based Medicine: Overview of the Main Steps for Developing and Grading for Guideline Recommendations

Scientific Committees

COMMITTEE 1 Epidemiology, Prevention, Screening, Diagnosis, and Evaluation

1.2 Epidemiology: General Statistics and Trends

1.3 Bladder Cancer Prevention

1.4 Screening and Early Detection

1.5 Endoscopic Examination of the Lower Urinary Tract

1.6 Transurethral Resection of Bladder Tumours

1.7 Imaging and Bladder Cancer

COMMITTEE 2 Pathology

2.2 Normal Urothelium and Bladder Wall Histoanatomy

2.3 Epithelial Changes and Flat Lesions

2.4 Grading of Bladder Cancer

BLADDER CANCER EDITORS: PETER BLACK, MD, FACS, FRCSC AND PAOLO GONTERO, MD A Joint SIU-ICUD International Consultation Lisbon, Portugal, October 19, 2017 Co-sponsored by SIU (Société International e d’Urologie) I CUD (International Consultation on Urological Diseases) [www.siu-urology.org](www.siu-urology.org) BLADDER CANCER EDITORS: PETER BLACK, MD, FACS, FRCSC AND PAOLO GONTERO, MD A Joint SIU-ICUD International Consultation Lisbon, Portugal, October 19, 2017 Co-sponsored by SIU (Société International e d’Urologie) I CUD (International Consultation on Urological Diseases) Bladder Cancer A Joint SIU-ICUD International Consultation Lisbon, Portugal, October 19, 2017 Editors Peter Black and Paolo Gontero Published by the Société Internationale d’Urologie (SIU) For information and orders: SIU Central Office 1155 Robert-Bourassa Blvd. Suite 1012 Montréal, Québec Canada H3B 3A7 T: +1 514 875-5665 F: +1 514 875-0205 E: [communications@siu-urology.org](communications@siu-urology.org) W: [www.siu-urology.org](www.siu-urology.org) ©2018 Société Internationale d’Urologie Cover image courtesy of Prof. Eva Compérat (Department of Pathology, Hôpital Tenon, Paris, France). Coordination: SIU Communications Office Managing Editor: Christine Albino Medical Copyediting and Proofreading: Nicholas Floratos, Namita Kumar, Stephanie MacLean, Areti Malapetsas, Stephanie Minelga, Catherine Muir, Jeany Papadionissiou. Layout and Design: SAM Design, Montréal, Canada All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior permission from the publisher. Accurate indications, adverse reactions, and dosage schedules for drugs are provided in this book, but it is possible that these may change after publication . The reader is urged to review the latest approved product information published by the manufacturers of the medications and medical devices mentioned in this book for the most up-to-date information . The publishers have made every effort to trace the copyright holders for borrowed material. If they have inadvertently overlooked any, they will be pleased to make the necessary arrangements at the first opportunity. ISBN: 978-1-7750334-1-7 [www.siu-urology.org](www.siu-urology.org) Table of Contents Abbreviations Used in the Text XVII Preface XXXV Introduction XXXVII Evidence-Based Medicine: Overview of the Main Steps for Developing and Grading for Guideline Recommendations XXXIX Scientific Committees XLV COMMITTEE 1 Epidemiology, Prevention, Screening, Diagnosis, and Evaluation 1 1.1 Introduction 5 1.2 Epidemiology: General Statistics and Trends 5 1.2.1 Introduction 5 1.2.2 Bladder cancer incidence and mortality 6 1.2.3 Cumulative risks of bladder cancer incidence and death 12 1.2.4 Time trends in incidence and mortality 15 1.2.5 Population-based survival estimates 20 1.2.6 Bladder cancer prevalence 20 1.2.7 A forecast into the quantitative burden of bladder cancer 21 1.3 Bladder Cancer Prevention 22 1.3.1 Introduction 22 1.3.2 Risk factors 22 1.3.3 Primary prevention of bladder cancer 24 1.3.4 Tertiary prevention of bladder cancer 26 1.3.5 Recommendations 29 1.4 Screening and Early Detection 30 1.4.1 Screening and detection: methodology 30 1.4.2 Screening general populations 30 1.4.3 Screening high-risk populations 30 1.4.4 Detection: hematuria 31 1.4.5 Detection: other 32 1.4.6 Recommendations 32 1.5 Endoscopic Examination of the Lower Urinary Tract: Methods, Techniques, Fluorescence, and Optical Advances 33 1.5.1 Introduction 33 1.5.2 White-light cystoscopy 33 1.5.3 Photodynamic diagnosis of bladder tumours 35 1.5.4 Narrow-band imaging of bladder tumours 44 1.5.5 New optical imaging techniques for evaluating bladder

FAQs

What meeting and organizations are associated with this bladder cancer consultation?

The book documents a joint SIU-ICUD international consultation held in Lisbon, Portugal on October 19, 2017, co-sponsored by SIU (Société Internationale d’Urologie) and I CUD (International Consultation on Urological Diseases).

Which clinical topics are covered in Committee 1?

Committee 1 addresses epidemiology, prevention, screening and early detection, endoscopic examination, transurethral resection techniques, and imaging roles in diagnosis, staging, and follow-up.

What pathology areas does Committee 2 include?

Committee 2 covers normal urothelium and bladder wall histoanatomy, epithelial changes and flat lesions, and grading of bladder cancer, including updates and interobserver/intraobserver considerations.

Aug 23, 2026

Uploaded by Rizky